Cologne - The private equity investor capiton has acquired a majority stake in the Wundex Group, a leading full-service provider for wound care in Germany. Capiton acquired the shares in the course of a structured bidding process from the previous majority shareholders BE Investment-Partners GmbH and the founders of the company. The two founders and managing directors of the group of companies will remain in their position as retroactive shareholders. The closing of the transaction is still subject to the usual approvals by the competent antitrust authorities. The parties have agreed not to disclose details of the transaction.
A CMS team led by partners Dr Malte Bruhns and Dr Thomas Sonnenberg provided comprehensive legal advice to BE Investment Partners GmbH and the founders of the Wundex Group.
The Wundex Group, based in Senden (North Rhine-Westphalia), specialises in the in-house development of high-quality relief systems in the field of anti-decubitus prophylaxis as well as the distribution of modern wound care products.
BE Investment-Partners GmbH, based in Cologne, specialises in active investment in medium-sized companies in Germany. The portfolio includes various companies from a wide range of industries.
CMS Germany
Dr Malte Bruhns, Lead Partner, Cologne
Dr Thomas Sonnenberg, Co-Lead Partner, Cologne
Laura Stein, Senior Associate, Cologne, all Corporate M&A
Dr Tobias Kilian, Principal Counsel, Frankfurt
Dr Dirk Baukholt, Counsel, Frankfurt, both W&I Insurance
Kai Neuhaus, Partner, Brussels
Moritz Pottek, Senior Associate, Brussels, both Merger Control
Patricia Jares, Principal Counsel, Cologne, Employment
Dr Martin Friedberg, Counsel, Dusseldorf, Tax law
Press Contact
presse@cms-hs.com
